Health and Healthcare

Zogenix, Inc. : ZGNX

ZGNX

Stock Data

$26.68

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All ZGNX Articles

29 Articles

Lee Jackson | Dec 21, 2020 at 8:15 AM EST

5 Top Biotech Stocks to Buy for 2021 With Massive Upside Potential

A new Stifel research report includes the firm's biotech stock picks for 2021. These five have the biggest upside to…

Jon C. Ogg | Aug 25, 2020 at 9:06 AM EDT

Top Analyst Upgrades and Downgrades: Crocs, Gap, GW Pharma, Lowe’s, Merck, Nio, Palo Alto, Phillips 66, Starbucks, Vital Farms and More

Tuesday's top analyst upgrades and downgrades included Crocs, Gap, GW Pharmaceuticals, Lowe's Companies, Merck, Nio, Palo Alto Networks, Phillips 66,…

Chris Lange | Jun 27, 2019 at 10:20 AM EDT

Thursday’s Top 4 Biotech Movers

Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a…

Chris Lange | Apr 9, 2019 at 10:05 AM EDT

Bad News for Epilepsy Seizure Patients Following FDA Update

Zogenix shares were crushed on Tuesday after the firm provided an update from the FDA regarding Fintepla for the treatment…

Jon C. Ogg | Sep 7, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Costco, GW Pharma, NXP, Southwest Air, Teva, Ulta, Wells Fargo and More

The top analyst upgrades, downgrades and initiations seen on Friday include Apple, Caterpillar, Costco, GW Pharmaceuticals, NXP Semiconductors, Southwest Airlines,…

Chris Lange | Jul 12, 2018 at 11:40 AM EDT

How Zogenix Is Winning Big With Late-Stage Seizure Study

Zogenix shares made a solid gain on Thursday after the company announced positive results from its late-stage seizure trial.

Jon C. Ogg | Nov 27, 2017 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline, Square and Many More

The top analyst upgrades, downgrades and other research calls from Monday include AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline and…

Chris Lange | Sep 29, 2017 at 8:40 AM EDT

Why Zogenix Shares More Than Doubled

Zogenix saw its shares more than double early on Friday after the company reported positive top-line results from its most…

Lee Jackson | Aug 12, 2016 at 8:25 AM EDT

Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as…

Lee Jackson | Oct 21, 2015 at 8:35 AM EDT

4 Analyst Stock Picks With 50% to 100% Upside Potential

Aggressive traders looking for solid ideas with big upside from all over Wall Street will like a new research note…

Chris Lange | Mar 14, 2015 at 9:25 AM EDT

5 Highly Unusual Stock Moves of the Past Week

Stocks are still very close to all-time highs, and this bull market is now six years old. It turns out…

Chris Lange | Mar 11, 2015 at 1:45 PM EDT

The Gamble That Did Not Pay Off

Zogenix has announced an agreement for the sale of its Zohydro ER (hydrocodone bitartrate) business to Pernix for $100 million.

Jon C. Ogg | Oct 4, 2014 at 9:11 AM EDT

8 Analyst Stocks Under $10 With Major Upside Calls

Analysts who cover low-priced and small-cap stocks often predict upside of 50%, 100% or much more. You just don't see…

Jon C. Ogg | Oct 2, 2014 at 12:40 PM EDT

Analyst Still Sees Zogenix Potentially Doubling

Oppenheimer's official rating on Zogenix remains Outperform, but what stands out is that the $2.50 price target implies that shares…

Jon C. Ogg | Mar 21, 2014 at 1:00 PM EDT

Zogenix CEO Goes on the Offensive

Zogenix has traded like a company that is about to implode. Its highly controversial Zohydro has been getting inquiries into…

1 2

Zogenix, Inc. : ZGNX

ZGNX

$26.68

All ZGNX Articles

5 Top Biotech Stocks to Buy for 2021 With Massive Upside Potential

Top Analyst Upgrades and Downgrades: Crocs, Gap, GW Pharma, Lowe’s, Merck, Nio, Palo Alto, Phillips 66, Starbucks, Vital Farms and More

Thursday’s Top 4 Biotech Movers

Bad News for Epilepsy Seizure Patients Following FDA Update

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Costco, GW Pharma, NXP, Southwest Air, Teva, Ulta, Wells Fargo and More

How Zogenix Is Winning Big With Late-Stage Seizure Study

Top Analyst Upgrades and Downgrades: AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline, Square and Many More

Why Zogenix Shares More Than Doubled

Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

4 Analyst Stock Picks With 50% to 100% Upside Potential

5 Highly Unusual Stock Moves of the Past Week

The Gamble That Did Not Pay Off

8 Analyst Stocks Under $10 With Major Upside Calls

Analyst Still Sees Zogenix Potentially Doubling

Zogenix CEO Goes on the Offensive

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Zogenix, Inc. : ZGNX

ZGNX

$26.68

All ZGNX Articles

5 Top Biotech Stocks to Buy for 2021 With Massive Upside Potential

Top Analyst Upgrades and Downgrades: Crocs, Gap, GW Pharma, Lowe’s, Merck, Nio, Palo Alto, Phillips 66, Starbucks, Vital Farms and More

Thursday’s Top 4 Biotech Movers

Bad News for Epilepsy Seizure Patients Following FDA Update

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Costco, GW Pharma, NXP, Southwest Air, Teva, Ulta, Wells Fargo and More

How Zogenix Is Winning Big With Late-Stage Seizure Study

Top Analyst Upgrades and Downgrades: AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline, Square and Many More

Why Zogenix Shares More Than Doubled

Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

4 Analyst Stock Picks With 50% to 100% Upside Potential

5 Highly Unusual Stock Moves of the Past Week

The Gamble That Did Not Pay Off

8 Analyst Stocks Under $10 With Major Upside Calls

Analyst Still Sees Zogenix Potentially Doubling

Zogenix CEO Goes on the Offensive

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026